Desmopressin for reducing postoperative blood loss and transfusion requirements following cardiac surgery in adults

Interactive Cardiovascular and Thoracic Surgery

Volumn 18, Issue 3, 2014, Pages 360-370

  Wademan, Brecon H ^a   Galvin, Sean D ^b  

^a WELLINGTON HOSPITAL   (New Zealand)

^b AUSTIN HOSPITAL   (Australia)

Author keywords

Cardiothoracic; Desmopressin acetate; Haemorrhage; Review; Surgery; Transfusion

Indexed keywords

ACETYLSALICYLIC ACID; DESMOPRESSIN ACETATE;

ADULT; AORTA STENOSIS; ARTICLE; BLOOD TRANSFUSION REACTION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; HEART SURGERY; HUMAN; META ANALYSIS (TOPIC); POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHEAR STRESS; SYSTEMATIC REVIEW; THROMBOCYTE DYSFUNCTION; THROMBOCYTE FUNCTION ANALYZER; UREMIA; VON WILLEBRAND DISEASE;

CARDIOTHORACIC; DESMOPRESSIN ACETATE; HAEMORRHAGE; REVIEW; SURGERY; TRANSFUSION;

ADULT; BENCHMARKING; BLOOD TRANSFUSION; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DEAMINO ARGININE VASOPRESSIN; EVIDENCE-BASED MEDICINE; HEMOSTATICS; HUMANS; PATIENT SELECTION; POSTOPERATIVE HEMORRHAGE; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84894682297     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivt491     Document Type: Article

References (20)

1. Dunning J, Prendergast B, MacKay-Jones K. Towards evidence-based medicine in cardiothoracic surgery: best BETS. Interact CardioVasc Thorac Surg 2003;2:405-409.
2. Cattaneo M, Harris AS, Stromberg U, Mannucci PM. The effect of desmopressin on reducing blood loss in cardiac surgery-a meta-analysis of double-blind, placebo-controlled trials. Thromb Haemost 1995;74:1064-70.
3. Levi M, Cromheecke ME, de Jonge E, Prins MH, de Mol BJM, Briet E et al. Pharmacological strategies to decrease excessive blood loss in cardiac surgery. A meta-analysis of clinically relevant end-points. Lancet 1999; 354:1940-7.
4. Carless PA, Stokes BJ, Moxey AJ, Henry DA. Desmopressin use for minimizing perioperative allogeneic blood transfusion. Cochrane Database Syst Rev 2004;1. Art. No.: CD001884.
5. Gratz I, Koehler J, Oslen D, Afshar M, DeCastro N, Spagna PM et al. The effect of desmopressin acetate on postoperative hemorrhage in patients receiving aspirin therapy before coronary artery bypass operations. J Thorac Cardiovasc Surg 1992;104:1417-22.
6. Sheridan DP, Card RT, Piniella JC, Harding SM, Thomson DJ, Gauthier L et al. Use of desmopressin acetate to reduce blood transfusion requirements during cardiac surgery in patients with acetylsalicylic-acid-induced platelet dysfunction. Can J Surg 1994;37:33-6.
7. Dilthey G, Dietrich W, Spannagl M, Richter JA. Influence of desmopressin acetate on homologous blood requirements in cardiac surgical patients pretreated with aspirin. J Cardiothorac Vasc Anesth 1993;7:425-30.
8. Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 1992;77:38-46.
9. Hackmann T, Gascoyne RD, Naiman SC, Growe GH, Burchill LD, Jamieson WR et al. A trial of desmopressin (1-deamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. N Engl J Med 1989; 321:1437-43.
10. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991;84:2063-70.
11. Reich DL, Hammerschlag BC, Rand JH, Weiss-Bloom L, Perucho H, Galla J et al. Desmopressin acetate is a mild vasodilator that does not reduce blood loss in uncomplicated cardiac surgical procedures. J Cardiothorac Vasc Anesth 1991;5:142-5.
12. de Prost D, Barbier-Boehm G, Hazebroucq J, Ibrahim H, Bielsky MC, Hvass U et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thromb Haemost 1992;68:106-10.
13. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Paramo JA. Randomized study of aprotinin and DDAVP to reduce postoperative bleeding after cardiopulmonary bypass surgery. Circulation 1994;90:921-7.
14. Depotis GJ, Levine V, Salem R, Spitznagel E, Joist JH. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery. A randomized controlled trial. Lancet 1999;354: 106-10.
15. Casas JI, Zuazu-Jausoro I, Mateo J, Oliver A, Litvan H, Muniz-Diaz E et al. Aprotinin versus desmopressin for patients undergoing operations with cardiopulmonary bypass. A double blinded placebo controlled study. J Thorac Cardiovasc Surg 1995;110(Pt 1):1107-17.
16. Temeck BK, Bachenheimer LC, Katz NM, Coughlin SS, Wallace RB. Desmopressin acetate in cardiac surgery. A double-blind, randomized study. South Med J 1994;87:611-5.
17. Salzman EW, Weinstein MJ, Weinstraub RM, Ware JA, Thurber RL, Robertson L et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery. A double-blind randomized trial. N Engl J Med 1986;314:1402-6.
18. Rocha E, Llorens R, Paramo JA, Arcas R, Cuestra B, Trenor AM. Does desmopressin acetate reduce blood loss after surgery in patients on cardiopulmonary bypass? Circulation 1988;77:1319-23.
19. Ansell J, Klassen V, Lew R, Ball S, Weinstein M, Vandersalm T et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomized, double-blind study. J Thorac Cardiovasc Surg 1992;104:117-23.
20. Steinlechner B, Zeidler P, Base E, Birkenberg B, Ankersmit HJ, Spannagl M et al. Patients with severe aortic valve stenosis and impaired platelet function benefit from pre-operative desmopressin infusion. Ann Thorac Surg 2011;91:1420-6.